INP Stock UPDATES India Index ETN MSCI Ipath (INP) 71.03 09/16/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
India Index ETN MSCI Ipath (INP) 71.03 $INP

Tata Motors Near High, Offers Secondary Buy Point
at Investor's Business Daily - Mon Sep 15, 5:09PM CDT
India-based automaker Tata Motors (TTM) has shaped a three-weeks-tight pattern as the stock holds near an all-time high. Tata, which has expanded abroad with its 2008 purchase of Jaguar/Land Rover from Ford (F), is about 4% below the 48.98 buy point....

INP, EIG, DBS, OREX, GXC, TEL Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Sep 12, 5:25AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of IPATH MSCI INDIA INDEX ETN (NYSE:INP), EMPLOYERS HOLDINGS INC (NYSE:EIG), PowerShares DB Silver Fund (NYSE BS), Orexigen Therapeutics Inc (NASDAQ:OREX), SPDR S&P China ETF (NYSE:GXC), TE Connectivity Ltd (NYSE:TEL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

India ETFs—Behind the Mayhem - ETF News And Commentary
Neena Mishra - ZACKS - Tue Aug 20, 9:10AM CDT
Many India ETFs have declined by more than 20% in the past three months.

India ETFs--Behind the Mayhem - ETF News And Commentary
Neena Mishra - ZACKS - Tue Aug 20, 9:10AM CDT
Many India ETFs have declined by more than 20% in the past three months.

Amid U.S. Correction, How Do Emerging Markets Fare?
at Investor's Business Daily - Fri Aug 16, 4:18PM CDT
Investors without borders must be at least on their alert after the U.S. market, which slid badly Thursday, entered a correction. Most emerging-market bourses are already underwater, and can ill afford more losses. Ranking these markets from first to...

Rupee Slide Hits Small Cap India ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 07, 2:00PM CDT
Small cap India ETFs have performed poorly lately. What is behind the slide?

GJS, PIKE, INP, LAG, DTO, EPI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jun 19, 6:23AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Synthetic FixedIncome Securities Inc. Floating Rate Structured Repackaged Asse (NYSE:GJS), Pike Electric Corp (NYSE IKE), IPATH MSCI INDIA INDEX ETN (NYSE:INP), SPDR Barclays Capital Aggregate Bond ETF (NYSE:LAG), POWERSHARES DB OIL 2X SHORT (NYSE TO), WisdomTree India Earnings Fund (NYSE:EPI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Two India ETFs Leading Emerging Markets Higher - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu May 09, 10:45AM CDT
Why India ETFs have been surging lately and which India investments have done the best.

IBKR, DCT, INP, MELA, GDX, HWCC Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Apr 24, 6:57AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of INTERACTIVE BROKERS GROUP, INC. (NASDAQ:IBKR), DCT Industrial Trust Inc (NYSE CT), IPATH MSCI INDIA INDEX ETN (NYSE:INP), MELA Sciences Inc (NASDAQ:MELA), Goldex Resources Corp (NYSE:GDX), Houston Wire & Cable Co (NASDAQ:HWCC) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Investing in India - ETFs
heavenhelllord@yahoo.com (Siddharth Dalal)via The Motley Fool - Motley Fool - Tue Feb 12, 10:30AM CST
India is one of the major emerging market economies. The Indian stock market is well established and the roots of the Bombay Stock Exchange (BSE) go all the way back to the mid 1800s, making it the oldest in Asia. It is the 10th largest...

Can India ETFs Continue Their Solid Run? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jan 21, 11:53AM CST
India ETFs have surged. Can they continue to run higher in 2013?




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 83

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

VivoPower Innovates with XRP-Focused Treasury Strategy

Updated Category News Views 359

VivoPower's Transformational XRP Strategy VivoPower International PLC (NASDAQ: VVPR) has recently embarked on a groundbreaking journey by announcing a new strategy centered on the digital asset XRP. The company is positioning itself as the first publicly traded entity to implement an XRP-focused digital asset treasury. This innovative approach is not only exciting for...

Continue Reading
Recognizing Excellence in Product Stewardship for 2024

Updated Category News Views 114

Celebrating Product Stewardship Excellence The Product Stewardship Society has announced a significant honor for 2024—Lynn L. Bergeson has been named the recipient of the prestigious Allan K. Fleeger Distinguished Service Award. This esteemed award has been established to acknowledge the remarkable contributions of individual product stewards who have played crucial...

Continue Reading
Gold Hits New Heights Amid Tensions and Election Uncertainty

Updated Category News Views 163

Gold Prices Surge to Record Heights In recent trading, gold prices have reached unprecedented levels, reflecting a significant rise driven by various factors, including political uncertainties and ongoing international conflicts. As anticipation surrounding a highly competitive U.S. presidential election grows, along with persistent tensions in regions such as the Middle...

Continue Reading
Paul Jebely Joins Sterlington as Aviation Law Vice Chair

Updated Category News Views 257

Paul Jebely Joins Sterlington as New Partner Sterlington PLLC is excited to announce that Paul Jebely has joined the firm as their new Partner and Vice Chair of International, marking a crucial advancement in their aviation law practice. Jebely is not just any attorney; he is a globally recognized authority in private aviation law, especially known for his work with...

Continue Reading
William James Wartinbee III Executes Significant Sell Strategy

Updated Category News Views 62

William James Wartinbee III Implements Key Sell Strategy In a noteworthy insider sale, William James Wartinbee III, the Executive Vice President at Gartner (IT), has sold 210 shares of the company. This transaction was documented in a Form 4 filing with the U.S. Securities and Exchange Commission, and the sale was valued at about $103,275. Examining Gartner's Current...

Continue Reading